iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Sees Significant Growth in Short Interest

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 7,895 shares, a growth of 158.5% from the July 15th total of 3,054 shares. Approximately 5.3% of the shares of the stock are sold short. Based on an average daily volume of 2,182 shares, the short-interest ratio is currently 3.6 days.

iShares Neuroscience and Healthcare ETF Price Performance

Shares of NYSEARCA:IBRN traded up $0.04 during midday trading on Friday, reaching $39.14. The company’s stock had a trading volume of 1,751 shares, compared to its average volume of 2,344. iShares Neuroscience and Healthcare ETF has a fifty-two week low of $24.12 and a fifty-two week high of $43.01. The business’s fifty day simple moving average is $37.56 and its 200-day simple moving average is $34.79. The company has a market capitalization of $5.87 million, a P/E ratio of 15.61 and a beta of 0.75.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.